reduce effect of confounding factors. Propensity score matching mimics some of the characteristics of Randomized Control Trial by balancing score of baseline covariates betweent study groups. The entire cohort of primaparas who were received care from Caseload Midwifery Program (n = 500) was matched with equal number of women who received standard midwifery care and low risk women who received GP-shared care. The women in the three groups were matched for age, body mass index (BMI) and country of birth.
reduce effect of confounding factors. Propensity score matching mimics some of the characteristics of Randomized Control Trial by balancing score of baseline covariates betweent study groups. The entire cohort of primaparas who were received care from Caseload Midwifery Program (n = 500) was matched with equal number of women who received standard midwifery care and low risk women who received GP-shared care. The women in the three groups were matched for age, body mass index (BMI) and country of birth.
Our results showed higher rates of normal vaginal birth, lower rates of instrumental birth, as well as lower rates of episiotomy and epidural use in labour for women who received care from Caseload Midwifery Program.The differences were statistically significant (p < 0.001) There was no statistically significant differences in neonatal Apgar's scores or rates of admission to nursery among the groups. Our study provides further evidence about effectiveness of continuity of midwifery care in reduction of rates of labour and birth intervention.
WOMEN WITH GDM AT WESTMEAD HOSPITAL : BIRTH OUTCOMES IN CONTEXT OF COUNTRY OF BIRTH
Beata Gidaszewski* Westmead Hospital At Westmead Hospital, the majority of our patients were born oversees and this proportion is steadily increasing. Migrant population can be remarkably different from general population in terms of prevalence of some health conditions and healthcare outcomes, such as gestational diabetes (GDM) (1, 2, 3). In the present research, we used routinely collected data of 51,577 women who birthed at Westmead hospital between July 2006 and June 2016. Data were coded and analysed using SPSS software. We used descriptive statistics to show prevalence of gestational diabetes amongst our population. Our study showed that out of 4,978 women who were diagnosed with GDM, the majority of them were born in countries on Indian subcontinent (34%, n = 1,665) or Asia (24%, n = 1,187). Australia-born women accounted for 37% of general population of our patients, however they represented less than 20% of women with GDM. We applied a multinomial logistic regression analysis to evaluate the effect of mother's country of birth on mode of birth amongst women diagnosed with GDM. In our analysis, we adjusted for maternal age, parity, gestational age, birth weight and use of epidural analgesia. Our results showed statistically significant differences (p References Dahlen, H.G., Schmied, V., Dennis, C., Thorton. C. (2013 Background: A cataract is an opacity of the lens of the eye that causes partial or total blindness. The diagnosis of bilateral congenital cataracts in the fetus is rare. Approximately one-third of congenital cataracts are inherited, one-third are idiopathic or sporadic and one-third are associated with systemic diseases. Common causes include intrauterine infections, metabolic disorders and chromosomal defects. In this paper, the authors report a case of bilateral cataracts diagnosed prenatally by ultrasound and associated to a postnatal diagnosis of Lowe syndrome. The authors also conduct a systematic review of previously reported cases Method: Review of the literature based mainly on PubMed, Scopus, Medline and the Cochrane Library Search using specific keywords and controlled vocabulary (e.g. prenatal ultrasound diagnosis of congenital abnormalities, congenital cataracts, Lowe syndrome and diagnosis of genetic syndromes) in order to list cataract cases diagnosed prenatally.
Results: Reports of bilateral cataracts diagnosed prenatally are very sporadic as cataracts are usually diagnosed after birth. There were less than ten cases of bilateral congenital cataracts reported in the literature. The reported cases were related to chromosomal abnormalities, idiopathic and or inherited. Only two cases were reported with association to Lowe syndrome.
Conclusions: Congenital cataract is a challenging condition to diagnose prenatally especially when it is identified as an isolated finding. However, the fact that it is usually associated to other fetal malformations or syndromes means lens opacities should be systematically searched for at prenatal ultrasound. University of New South Wales, the 2 University of Sydney
CLINICAL PRACTICE GUIDELINES FOR

Background:
The global incidence of neonatal abstinence syndrome (NAS) has risen dramatically in the last decade but it is unclear whether practice guidelines are of sufficient quality to guide clinical management.
Method: A systematic review was undertaken using publically available databases with search terms "neonatal abstinence", "withdrawal", "opioids" and "guidelines". Full text guidelines published since database inception and without language restriction were included. The Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument was used to assess guideline quality.
Results: A total of 4182 articles were screened and 17 were included in the review. In general, the guidelines scored lowest in rigour of development and editorial independence. Only one of 17 guidelines adhered to all AGREE II methodological criteria and was recommended for use in clinical practice. Five guidelines were recommended for use with modifications and require greater transparency in their methodology for formulating evidence-based recommendations for clinical practice. All guidelines lacked specific recommendations regarding discharge planning, follow-up and child protection whilst none of the guidelines discussed assessment or management of long-term complications associated with intra-uterine drug-exposure such as neurodevelopmental delay and visual disorders.
Conclusions:
Existing clinical practice guidelines for NAS are generally of low quality and lack specific recommendations regarding discharge planning, follow-up, child protection or long-term medical management. Review is needed to assist in guiding best clinical care for this vulnerable group of children and their families. Cerebral palsy (CP) is one of the most common severe physical disabilities in childhood. Children with CP show a broad spectrum of severity, and most participate in the mainstream school system. We described standardised Year 3 test results among children with CP.
EDUCATIONAL OUTCOMES FOR CHILDREN WITH
Method: We identified children with CP in NSW hospital inpatient records using ICD-10-AM codes and classified their motor symptom topography and co-morbid chronic conditions. We analysed linked records of educational outcomes (NAPLAN) for third-grade children for 2008-2014 in NSW government schools, including the relationship with disabilities.
Results: There were 3954 individuals with CP of whom 3089 were NSW-born. Seven hundred and sixty-six children had a linked 3rd grade NAPLAN record. Half of these children were exempt from the reading task (vs 1% among children without CP) and 32% attained a Z score > −1. Twenty percent had special needs adjustments when completing tests. Results for numeracy were similar. Children with more severe topography of motor symptoms or with chronic conditions including epilepsy and impaired hearing were more likely to be exempt from NAPLAN testing, and achieved lower scores.
Conclusions: While children with CP participate in mainstream schooling, half are excluded from NAPLAN tests. Multiple aspects of CP-related disability limit participation and attainment. Background: The use of complementary and herbal medicines has been increasing in pregnant women worldwide, despite limited safety data in pregnancy. The aim of this study was to explore the recommendations and information sources healthcare professionals use to determine the safety of non-prescribed supplements during pregnancy.
Method: An electronic survey was distributed to doctors, midwives, pharmacists, dieticians, lactation consultants and physiotherapists caring for pregnant patients at an Australian maternity hospital.
Results:
Responses were received from 54 healthcare professionals. Forty of 54 (74.1%) were concerned about the safety of their patients' supplements, while 35 of 54 (64.8%) felt they had access to trustworthy safety information. Supplements most commonly recommended to patients as safe to use were ginger (40.7%), probiotics (29.6%) and raspberry leaf (22.2%). Participants specifically requested further safety information for raspberry leaf, evening primrose oil, fish oil, probiotics, ginger, vitamin C, valerian, turmeric, blue kohosh and colloidal silver. Written resources most frequently consulted included MIMS (61.1%) and 'Google Searches' (29.6%), and health professionals most referred to were pharmacists (74.1%), doctors (22.2%), and naturopaths or herbalists (3.7%).
Conclusions: While most maternity healthcare professionals expressed concern about the safety of patient's self-initiated complementary or herbal supplements in pregnancy, their recommendations and the quality of information sources varied. Further education and access to unbiased safety information is required to empower healthcare professionals to provide informed recommendations to pregnant patients. Background: Infants at risk of neonatal hypoglycaemia are often screened using cot-side glucometers, but non-enzymatic glucometers are inaccurate, potentially resulting in over-and under-treatment, and low values require laboratory confirmation. More accurate enzymatic glucometers are available but apparently higher ward costs discourage their use. Our objective was to compare the cost of screening for neonatal hypoglycaemia using point-of-care enzymatic and non-enzymatic glucometers.
COST ANALYSIS OF COT-SIDE SCREENING METHODS
Method: A decision tree model was constructed using incidence data from the Sugar Babies Study. Costs evaluated include consumables and staff time. Sensitivity analyses assessed the impact of varying staff time, staff costs, probability that low results are confirmed via laboratory testing, the false positive and false negative rates of non-enzymatic glucometers, and the blood glucose concentration threshold.
Results: In the primary analysis, screening using an enzymatic glucometer costs NZ$86.94 while using a non-enzymatic glucometer costs NZ$97.08 per infant. Sensitivity analyses show that an enzymatic glucometer is cost saving with wide variations in staff time and costs, with any level of false positive rate of nonenzymatic glucometers, or if the proportion of laboratory confirmation of low values is ? 78%. Non-enzymatic glucometers are less costly if their false negative rate is increased beyond 15%, but instances of hypoglycaemia will be missed. Reducing the blood glucose concentration threshold to 1.94 mmol/L reduced the incidence of hypoglycaemia, and the cost of screening using a non-enzymatic glucometer to NZ$47.71.
Conclusions: In view of their lower cost under most circumstances and greater accuracy, enzymatic glucometers should be routinely utilised for point-of-care screening for neonatal hypoglycaemia.
